Posted by This workshop is part of the NextNano4Cancer project, funded under the ERA4Health Joint Transnational Call “Nano and advanced technologies for disease prevention, diagnostic and therapy”. The project develops the next generation of nanocontainers for cancer treatment, focusing on supramolecular complexes built from macrocycles (cyclodextrins, calixarenes, dynarenes) and novel casein kinase 2 inhibitors. The aim is to create innovative, injectable nanomedicines that overcome multidrug resistance and improve therapeutic efficiency in aggressive cancers.
Aim of the Workshop Series
The semi-annual workshops hosted by the consortium aim to share the latest advancements in nanomedicine and oncotherapy, strengthen collaboration between academia, industry, and clinicians, actively engage stakeholders, patient groups, and young researchers, and provide a platform for responsible, co-creative dialogue on the ethical, social, and translational dimensions of cancer nanotechnology.
Programme (31 October)
13:00 – 13:10 (CET)
Ildikó Bácskay
Dean, Faculty of Pharmacy, University of Debrecen Opening
Opening Remarks
13:10 – 13:30
Andrea Furka
Assistant Professor, Department of Oncology, University of Debrecen
New developments in oncology: use of CK-2 inhibitors in therapy
13:30
István Puskás
Scientific Director, CycloLab Cyclodextrin Research and Development Laboratory Ltd.
Cyclodextrins as versatile representatives of carbohydrate-based nanotechnology
13:50 – 14:10
Ferenc Fenyvesi
Head of Department, Associate Professor, Department of Molecular and Nanopharmaceuticals, University of Debrecen
Application of macrocycles in nanomedicine
14:10 – 14:40
Q&A and facilitated discussion
Interactive Format
The workshop will take place on the Gather.town collaborative platform, which provides an interactive environment that facilitates both formal presentations and informal discussions among participants.
Registration is required on this link: https://forms.gle/NHjZ8xMfhkyhrpCD6
Please, register by 28 October, 16:00 CET.
The event link will be sent to registered participants.